A reference measurement of circulating ATPase inhibitory factor 1 (IF1) in humans by LC-MS/MS: Comparison with conventional ELISA
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Institut National de la Santé et de la Recherche Médicale
This publication has 15 references indexed in Scilit:
- Fenofibrate decreases plasma ceramide in type 2 diabetes patients: A novel marker of CVD?Diabetes & Metabolism, 2018
- Plasma PCSK9 measurement by liquid chromatography–Tandem mass spectrometry and comparison with conventional ELISAJournal of Chromatography B, 2016
- Serum levels of mitochondrial inhibitory factor 1 are independently associated with long-term prognosis in coronary artery disease: the GENES StudyBMC Medicine, 2016
- Multiplexed peptide analysis for kinetic measurements of major human apolipoproteins by LC/MS/MSJournal of Lipid Research, 2016
- PKA Phosphorylates the ATPase Inhibitory Factor 1 and Inactivates Its Capacity to Bind and Inhibit the Mitochondrial H+-ATP SynthaseCell Reports, 2015
- Serum IF1 concentration is independently associated to HDL levels and to coronary heart disease: the GENES studyJournal of Lipid Research, 2013
- Mitochondrial Inhibitory Factor 1 (IF1) Is Present in Human Serum and Is Positively Correlated with HDL-CholesterolPLOS ONE, 2011
- Mitochondrial and cell-surface F0F1ATPsynthase in innate and acquired cardioprotectionJournal of Bioenergetics and Biomembranes, 2009
- Ectopic β-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosisNature, 2003
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986